Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non–small cell lung cancer: Results of CALGB Protocol 39803

Objective Accurate pathologic restaging of N2 stations after neoadjuvant therapy in stage IIIA (N2) non–small cell lung cancer is needed. Methods A prospective multi-institutional trial was designed to judge the feasibility of videothoracoscopy to restage the ipsilateral nodes in mediastinoscopy-pro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of thoracic and cardiovascular surgery 2013-07, Vol.146 (1), p.9-16
Hauptverfasser:	Jaklitsch, Michael T., MD, Gu, Lin, MS, Demmy, Todd, MD, Harpole, David H., MD, D'Amico, Thomas A., MD, McKenna, Robert J., MD, Krasna, Mark J., MD, Kohman, Leslie J., MD, Swanson, Scott J., MD, DeCamp, Malcolm M., MD, Wang, Xiaofei, PhD, Barry, Susan, BS, Sugarbaker, David J., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery Carcinoma, Non-Small-Cell Lung - therapy Cardiothoracic Surgery Feasibility Studies Female Humans Lung Neoplasms - pathology Lung Neoplasms - surgery Lung Neoplasms - therapy Male Mediastinum Middle Aged Neoadjuvant Therapy Neoplasm Staging Prospective Studies Thoracic Surgery, Video-Assisted Thoracoscopy - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!